Roumell Asset Management, LLC
- SEC CIK
- 0001331693
- Latest filing
- Aug 13, 2024
The latest 13F from Roumell Asset Management, LLC covers Q2 2024 (filed Aug 13, 2024): 16 long positions worth $53.3M. The top 10 holdings make up 84.6% of the portfolio, and the largest is Olo Inc. (OLO) at 11.1%. Livermore has 14 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2024
Share counts compared with Q1 2024: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 0
- Added
- 5
- Est. +$5.56M
- Reduced
- 3
- Est. −$2.59M
- Sold out
- 1
- Est. −$1.73M
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q2 2024, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $53.3M
- +$155.6K (+0.3%) vs. prior quarter
- Positions
- 16
- −1 vs. prior quarter
- Top 10 concentration
- 84.6%
- Top 10 as share of value
- Turnover
- 8.1%
- Q2 2024, one quarter
- Average holding period
- 6.1 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
14 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $85.6M (Q2 2021)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2024 | Aug 13, 2024 | 16 | $53.3M | OLOOPRALBRT | vs. Q1 2024 | SEC |
| Q1 2024 | May 14, 2024 | 17 | $53.1M | LBRTOPRAOLO | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 13, 2024 | 15 | $46.5M | LBRTMGNIOPRA | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 13, 2023 | 19 | $49.7M | LBRTPTENMGNI | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 11, 2023 | 22 | $50.9M | NEXCLGNLBRT | vs. Q1 2023 | SEC |
| Q1 2023 | May 12, 2023 | 20 | $44.2M | OPRACLGNLBRT | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 13, 2023 | 21 | $40.4M | OPRACLGNTTI | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 10, 2022 | 21 | $46.2M | GSITENZBMGNI | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 12, 2022 | 21 | $51.4M | GSITMGNIENZB | vs. Q1 2022 | SEC |
| Q1 2022 | May 13, 2022 | 19 | $61.9M | GSITENZBCLGN | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 11, 2022 | 21 | $75.0M | GSITQMCOCLGN | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 12, 2021 | 17 | $75.5M | GSITENZBCLGN | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 13, 2021 | 18 | $85.6M | CLGNGSITALLT | vs. Q1 2021 | SEC |
| Q1 2021 | May 14, 2021 | 14 | $69.2M | ALLTGSITENZB | – | SEC |
13D and 13G filings
Companies where Roumell Asset Management, LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
Roumell Asset Management, LLC does not currently report owning 5% or more of any company.
Latest filings
20 filings on file made by Roumell Asset Management, LLC or listing it as a reporting person, newest first.
| Company | Filed (ET) | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| GSITGsi Technology Inc | Feb 13, 2024 | 13G/AOld format | – | – | – | SEC |
| CLGNCollPlant Biotechnologies Ltd | Feb 13, 2024 | 13G/AOld format | – | – | – | SEC |
| CLGNCollPlant Biotechnologies Ltd | Feb 13, 2023 | 13GOld format | – | New | – | SEC |
| QUMUQumu Corp | Feb 13, 2023 | 13G/AOld format | – | – | – | SEC |
| GSITGsi Technology Inc | Jan 20, 2023 | 13GOld format | – | – | – | SEC |
| ENZBEnzo Biochem Inc | Mar 25, 2022 | 13D/AOld format | – | – | – | SEC |
| TTITetra Technologies Inc | Feb 11, 2022 | 13G/AOld format | – | – | – | SEC |
| QUMUQumu Corp | Feb 11, 2022 | 13GOld format | – | New | – | SEC |
| RIBTRiceBran Technologies | Feb 11, 2022 | 13G/AOld format | – | – | – | SEC |
| BCDABioCardia, Inc. | Feb 7, 2022 | 13D/AOld format | – | – | – | SEC |
| GSITGsi Technology Inc | Jan 20, 2022 | 13D/AOld format | – | – | – | SEC |
| ENZBEnzo Biochem Inc | Sep 30, 2021 | 13D/AOld format | – | – | – | SEC |
| BCDABioCardia, Inc. | Sep 22, 2021 | 13DOld format | – | New | – | SEC |
| GSITGsi Technology Inc | Sep 14, 2021 | 13DOld format | – | – | – | SEC |
| ENZBEnzo Biochem Inc | May 5, 2021 | 13D/AOld format | – | – | – | SEC |
| GSITGsi Technology Inc | Feb 12, 2021 | 13GOld format | – | New | – | SEC |
| TTITetra Technologies Inc | Feb 12, 2021 | 13GOld format | – | New | – | SEC |
| RIBTRiceBran Technologies | Feb 12, 2021 | 13GOld format | – | New | – | SEC |
| ENZBEnzo Biochem Inc | Jan 15, 2021 | 13D/AOld format | – | – | – | SEC |
| ENZBEnzo Biochem Inc | Jan 5, 2021 | 13D/AOld format | – | – | – | SEC |